Plural, Cherry Ventures and Kindred Ventures led a €27.2m Series A round in Robeaute.

Plural, Cherry Ventures and Kindred Ventures led a €27.2m Series A round in Robeaute, a Paris-based medtech startup developing neurosurgical microrobots, with participation from LocalGlobe, Think.Health, APEX Ventures and Brainlab. "There is unexplored potential for microrobots in medicine. Current neurosurgery techniques are invasive and can be fatal, whilst it is difficult for treatment to pass the blood-brain barrier and get to its intended target. We are creating microrobots that will bring unparalleled access to the brain with personalised, precision medicine that can transform treatments and patient outcomes," Bertrand Duplat, Robeaute CEO.